Oxford Biomedica (OXB) Stock Chart & Stock Price History GBX 324 +1.00 (+0.31%) As of 08:33 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Oxford Biomedica Stock Price Performance The Oxford Biomedica (OXB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1.09%, with a year-to-date return of -22.86%. In the past month, the stock has increased 12.31%, reflecting recent market activity. As of the latest close, Oxford Biomedica traded at GBX 323 with a market cap of £343.35 million and volume of 139,769 shares. Five years ago, the stock traded at GBX 771, representing a 57.98% decrease over that period. At the time, it had a market cap of £593.55 million and a volume of 304,490 shares. Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.25%1 Month Performance+12.31%3 Month Performance-1.82%Year-To-Date Performance-22.86%1 Year Performance+1.09%5 Year Performance-57.98% OXB Stock Chart for Friday, May, 30, 2025 OXB Chart by TradingView Oxford Biomedica Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/29/2025GBX 312GBX 323+3.53%GBX 326.50GBX 311139,769 shs£343.35 million05/28/2025GBX 328.50GBX 312-5.02%GBX 335GBX 309.5092,758 shs£331.66 million05/27/2025GBX 320GBX 328.50+2.66%GBX 332GBX 314.50111,831 shs£349.20 million05/26/2025GBX 320GBX 320GBX 324GBX 291159,140 shs£340.16 million05/23/2025GBX 303.50GBX 320+5.44%GBX 324GBX 291159,140 shs£340.16 million05/22/2025GBX 304.50GBX 303.50-0.33%GBX 304.50GBX 29965,557 shs£322.62 million05/21/2025GBX 307.50GBX 304.50-0.98%GBX 309.13GBX 30253,750 shs£323.69 million05/20/2025GBX 298GBX 307.50+3.19%GBX 308.50GBX 297.0491,894 shs£326.88 million05/19/2025GBX 302GBX 298-1.32%GBX 298GBX 288.50200,936 shs£316.78 million05/16/2025GBX 296GBX 302+2.03%GBX 302GBX 29533,677 shs£321.03 millionBuffett’s Next Move Could Shock Wall Street (Ad)In just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next great gold rush. Savvy insiders are quietly positioning now… before Buffett makes it official. Garrett Goggin has already pinpointed four tiny-gold-miners that could 100X once the announcement hits. It’s the perfect moment to be greedy — before the herd wakes up. Get Garrett’s Top Four gold picks now — before the world’s greatest investor pulls the trigger.05/15/2025GBX 290GBX 296+2.07%GBX 310GBX 29070,176 shs£314.65 million05/14/2025GBX 292GBX 290-0.68%GBX 295.50GBX 289142,504 shs£308.27 million05/13/2025GBX 295GBX 292-1.02%GBX 299.45GBX 292108,532 shs£310.40 million05/12/2025GBX 296.50GBX 295-0.51%GBX 309GBX 294113,343 shs£313.59 million05/09/2025GBX 286GBX 296.50+3.67%GBX 297.50GBX 289293,898 shs£315.18 million05/08/2025GBX 277GBX 286+3.25%GBX 286GBX 270181,303 shs£304.02 million05/07/2025GBX 300GBX 277-7.67%GBX 299GBX 270.50282,043 shs£294.45 million05/06/2025GBX 295GBX 300+1.69%GBX 306GBX 291243,373 shs£318.90 million05/05/2025GBX 295GBX 295GBX 298GBX 28063,639 shs£313.59 million05/02/2025GBX 295GBX 295GBX 298GBX 28063,639 shs£313.59 million05/01/2025GBX 288.50GBX 295+2.25%GBX 297GBX 287.50124,748 shs£313.59 million04/30/2025GBX 297.50GBX 288.50-3.03%GBX 304GBX 283.50121,723 shs£306.68 million04/29/2025GBX 304GBX 297.50-2.14%GBX 307GBX 291207,227 shs£316.25 million Related Companies Oxford Nanopore Technologies Stock Price Chart PureTech Health Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart hVIVO Stock Price Chart Avacta Group Stock Price Chart Scancell Stock Price Chart Ondine Biomedical Stock Price Chart SkinBioTherapeutics Stock Price Chart Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OXB) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Musk’s Frightening Warning Forces Trump’s HandElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.